FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer

Journal of Urology

Volumn 189, Issue 5, 2013, Pages 1687-1691

  Mertens, Laura S ^a   Fioole Bruining, Annemarie ^a   Van Rhijn, Bas W G ^a   Kerst, J Martijn ^a   Bergman, André M ^a   Vogel, Wouter V ^a   Vegt, Erik ^a   Horenblas, Simon ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

carcinoma; fluorodeoxyglucose F18; positron emission tomography and computed tomography; urinary bladder; urothelium

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PELVIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS;

EID: 84876286706     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.009     Document Type: Article

References (24)

1. J.J. Meeks, J. Bellmunt, B.H. Bochner A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol 62 2012 523
2. H.B. Grossman, R.B. Natale, C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859
3. J. Bellmunt, A. Ribas, J. Albanell M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladder Am J Clin Oncol 19 1996 344
4. R. Rosenblatt, A. Sherif, E. Rintala Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer Eur Urol 61 2012 1229
5. J.B. Jensen, B.P. Ulhoi, K.M. Jensen Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer Scand J Urol Nephrol 45 2011 436
6. C.N. Sternberg, V. Pansadoro, F. Calabro Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 97 2003 1644
7. J.E. Husband, L.H. Schwartz, J. Spencer Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society Br J Cancer 90 2004 2256
8. A.B. Apolo, J. Riches, H. Schöder Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer J Clin Oncol 28 2010 3973
9. A.S. Kibel, F. Dehdashti, M.D. Katz Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma J Clin Oncol 27 2009 4314
10. G. Swinnen, A. Maes, H. Pottel FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer Eur Urol 57 2010 641
11. H. Schöder, S.C. Ong, V.E. Reuter Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer Mol Imaging Biol 14 2012 245
12. C. Rousseau, A. Devillers, M. Campone FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients Eur J Nucl Med Mol Imaging 38 2011 1029
13. N.M. Graafland, R.A. Valdes Olmos, H.J. Teertstra 18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results Eur J Nucl Med Mol Imaging 37 2010 1474
14. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind TNM Classification of Malignant Tumours 7th ed. 2009 Wiley-Blackwell Hoboken
15. M.D. Galsky, N.M. Hahn, J. Rosenberg A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy Lancet Oncol 12 2011 211
16. L.S. Mertens, R.P. Meijer, J.M. Kerst Carboplatin based induction chemotherapy for nonorgan confined bladder cancer - a reasonable alternative for cisplatin unfit patients? J Urol 188 2012 1108
17. H. Young, R. Baum, U. Cremerius Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 35 1999 1773
18. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists Lancet 354 1999 533
19. Advanced Bladder Cancer (ABC) Meta-Analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration Eur Urol 48 2005 202
20. P.U. Malmström, E. Rintala, R. Wahlqvist Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I The Nordic Cooperative Bladder Cancer Study Group J Urol 155 1996 1903
21. G. Griffiths, R. Hall, R. Sylvester International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial J Clin Oncol 29 2011 2171
22. A. Sherif, E. Rintala, O. Mestad Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer - Nordic cystectomy trial 2 Scand J Urol Nephrol 36 2002 419
23. L.S. Mertens, N.M. Bruin, E. Vegt Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study Nucl Med Commun 33 2012 1195
24. D.A. Anjos, E.C. Etchebehere, C.D. Ramos 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer J Nucl Med 48 2007 764